Materials Healthcare Sector

Septerna

Market Cap: US$450.9m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Claritev

Market Cap: US$449.5m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

kneat.com

Market Cap: CA$623.0m

Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.

Tilray Brands

Market Cap: US$439.8m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

LifeMD

Market Cap: US$439.5m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Capricor Therapeutics

Market Cap: US$437.0m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Bioventus

Market Cap: US$434.0m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

REGENXBIO

Market Cap: US$433.4m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Personalis

Market Cap: US$431.9m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Fortrea Holdings

Market Cap: US$430.1m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Cullinan Therapeutics

Market Cap: US$427.3m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Oxford Biomedica

Market Cap: UK£320.1m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Treace Medical Concepts

Market Cap: US$424.6m

A medical technology company, designs, manufactures, and markets medical devices in the United States.

SIGA Technologies

Market Cap: US$422.9m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

PureTech Health

Market Cap: UK£314.2m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Verastem

Market Cap: US$417.1m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Knight Therapeutics

Market Cap: CA$581.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Northwest Biotherapeutics

Market Cap: US$414.2m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

Sage Therapeutics

Market Cap: US$413.9m

A biopharmaceutical company, develops and commercializes brain health medicines.

Zenas BioPharma

Market Cap: US$407.5m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Vitalhub

Market Cap: CA$569.6m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

Maze Therapeutics

Market Cap: US$405.1m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

MeiraGTx Holdings

Market Cap: US$405.0m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Amylyx Pharmaceuticals

Market Cap: US$402.9m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Surmodics

Market Cap: US$400.8m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.

Standard BioTools

Market Cap: US$398.8m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

Tourmaline Bio

Market Cap: US$398.7m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Celcuity

Market Cap: US$398.4m

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

EyePoint Pharmaceuticals

Market Cap: US$393.6m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Australian Clinical Labs

Market Cap: AU$610.9m

Provides pathology diagnostic services in Australia.

Precigen

Market Cap: US$386.7m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Tectonic Therapeutic

Market Cap: US$386.1m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

Sana Biotechnology

Market Cap: US$385.7m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Verve Therapeutics

Market Cap: US$385.1m

A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.

Organogenesis Holdings

Market Cap: US$384.4m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Myriad Genetics

Market Cap: US$380.7m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.